We showed that cyclooxygenase-2 (COX-2), the key enzyme in the conversion of arachidonic acid to prostaglandins, involved in critical steps of tumor onset and progression [10], is a strong predictor of chemotherapy resistance and poor outcome in advanced ovarian cancer, as well as cervical cancer patients [12-14]. Here, PTGS2 is linked to ovarian cancer.